China Biologic Products, Inc. (CBPO): Ming Yin , Senior Corporate VP of China Biologic Products, Inc. sold 19,618 shares on May 19, 2016. The Insider selling transaction was reported by the company on May 23, 2016 to the Securities and Exchange Commission. The shares were sold at $113.61 per share for a total value of $2,229,399.50 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 23, 2016, Ming Yang (Chief Financial Officer) sold 13,908 shares at $113.61 per share price.On Mar 15, 2016, Zhijing Cbpo Liu (Corporate Vice President) sold 282 shares at $108.00 per share price.Also, On Mar 9, 2016, Min Fang (director) sold 4,257,000 shares at $107.00 per share price.On Dec 8, 2015, Zhijun Tong (director) sold 15,000 shares at $118.67 per share price.
China Biologic Products Inc: On Friday, May 20, 2016 heightened volatility was witnessed in China Biologic Products Inc which led to swings in the share price. The shares opened for trading at $113.84 and hit $114.32 on the upside , eventually ending the session at $113.75, with a gain of 0.96% or 1.08 points. The heightened volatility saw the trading volume jump to 1,56,395 shares. The 52-week high of the share price is $144.2899 and the company has a market cap of $3,024,726 M . The 52-week low of the share price is at $80.6.
Company has been under the radar of several Street Analysts.China Biologic Products Inc is Downgraded by Credit Suisse to Neutral. Earlier the firm had a rating of Outperform on the company shares. The Rating was issued on Mar 1, 2016.
China Biologic Products Inc. (China Biologic) is a biopharmaceutical company. The Company is principally engaged in the research development manufacturing and sales of human plasma-based biopharmaceutical products in China. China Biologic has a product portfolio with over 20 different dosage forms of plasma products. The Company’s principal products are human albumin and immunoglobulin for intravenous injection (IVIG). China Biologic operates its business through two subsidiaries namely Shandong Taibang Biological Products Co. Ltd. and Guizhou Taibang Biological Products Co. Ltd. The Company also holds an interest in Xi’an Huitian Blood Products Co. Ltd. a plasma products company. Its products include human albumin human immunoglobulin IVIG thymopolypeptides injection human hepatitis B immunoglobulin human rabies immunoglobulin human tetanus immunoglobulin placenta polypeptide Factor VIII and human prothrombin complex concentrate (PCC).